Vanguard Pharma Notes Growth of Medical Diagnostics/Testing Products
July 7, 2016 09:28 AM
Vanguard Pharma, fresh from signing a new multi-year deal in the diagnostics business, has noted this field to be rapidly growing and holding much promise for the future.
Kevin Danylchuk, Vanguard’s president and general manager, noted, “We continue to diversify in the products and services that we help promote on behalf of our clients. A growing trend for our business has been to assist companies in the fields of diagnostics, pharmacogenetics and in-office medical assessments. These products and services often bring a unique clinical benefit to help physicians better understand the patients' issues and lead ultimately to better overall care. We look forward to continued growth in this important and burgeoning field of medicine."